Question 1

Does Toronto-Dominion Bank own ONCY stock?

Accepted Answer

No. Toronto-Dominion Bank exited its ONCY (Oncolytics Biotech) position in Q3 2025. Its Q2 2025 13F listed 12,908 shares worth $9,864.

Question 2

How many shares of ONCY does Toronto-Dominion Bank own?

Accepted Answer

None since Q3 2025, when Toronto-Dominion Bank exited the position. Its Q2 2025 13F listed 12,908 shares worth $9,864.

Question 3

What is Toronto-Dominion Bank's ONCY position worth?

Accepted Answer

Toronto-Dominion Bank's ONCY position was worth $9,864 in its Q2 2025 13F, before the exit in Q3 2025.

Question 4

Is Toronto-Dominion Bank buying or selling ONCY?

Accepted Answer

In Q3 2025, Toronto-Dominion Bank exited its entire ONCY position.

Question 5

When did Toronto-Dominion Bank first buy ONCY?

Accepted Answer

Toronto-Dominion Bank already held ONCY in its Q3 2019 13F, the earliest on record, and listed it in 16 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2025-Q3 Latest	Exited	0	-100.0%	$0	0.0%	$1.40	0
2025-Q2	New	12,908	—	$9,864	0.0%	$0.77	26
2025-Q1	Exited	0	—	$0	0.0%	$0.55	0
2024-Q4	New	0	—	$0	0.0%	$0.91	17
2024-Q3	Exited	0	-100.0%	$0	0.0%	$0.87	0